About Us

Archives






Immutep Announces Chinese Patent Grant for LAG-3 Antagonist Antibody LAG525

Posted: August 29, 2021 at 1:49 am


Sydney, Aug. 27, 2021 (GLOBE NEWSWIRE) -- SYDNEY, AUSTRALIA – 27 August 2021 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), is pleased to announce the grant of patent no. ZL201580013695.X entitled “Antibody molecules to LAG-3 and uses thereof” by the Chinese Patent Office.

Original post:
Immutep Announces Chinese Patent Grant for LAG-3 Antagonist Antibody LAG525

Related Post

No Comments

No comments yet.

Sorry, the comment form is closed at this time.